Insulet Corp (NAS:PODD)
$ 200.45 -1.39 (-0.69%) Market Cap: 14.04 Bil Enterprise Value: 14.69 Bil PE Ratio: 60.74 PB Ratio: 17.75 GF Score: 84/100

Insulet Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 02:10PM GMT
Release Date Price: $265.82 (+4.39%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone. I'm Robbie Marcus, med-tech analyst at JPMorgan. I'm very happy to have Insulet for our next presentation. We're going to have CEO, Shacey Petrovic, lead the presentation and Q&A.

Just some housekeeping reminders. Go ahead to the health care website, and you can follow along with the slide deck to Shacey's remarks. Also, you can e-mail a question to me, and I can ask it in Q&A,or submit a question on the conference website, and I'll do my best to ask in Q&A.

So with that, Shacey, take it away.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Great. Thanks, Robbie. It's great to be here with you and to have the opportunity to share Insulet's great growth story with everyone. If we could open up the presentation? Great.

So Insulet, for those of you that are not familiar, is a company centered on a simple but powerful mission to improve the lives of people living with diabetes. We are the manufacturer of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot